Showing 1 posts of 1 posts found.
The European Commission has granted marketing authorisation to GlaxoSmithKline’s new diabetes treatment Eperzan – setting the manufacturer on a collision …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO